title: Inhibition of phosphodiesterase 4 reduces ethanol intake and preference in C57BL/6J mice.
abstract: Some anti-inflammatory medications reduce alcohol consumption in rodent models. Inhibition of phosphodiesterases (PDE) increases cAMP and reduces inflammatory signaling. Rolipram, an inhibitor of PDE4, markedly reduced ethanol intake and preference in mice and reduced ethanol seeking and consumption in alcohol-preferring fawn-hooded rats (Hu et al., 2011; Wen et al., 2012). To determine if these effects were specific for PDE4, we compared nine PDE inhibitors with different subtype selectivity: propentofylline (nonspecific), vinpocetine (PDE1), olprinone, milrinone (PDE3), zaprinast (PDE5), rolipram, mesopram, piclamilast, and CDP840 (PDE4). Alcohol intake was measured in C57BL/6J male mice using 24-h two-bottle choice and two-bottle choice with limited (3-h) access to alcohol. Only the selective PDE4 inhibitors reduced ethanol intake and preference in the 24-h two-bottle choice test. For rolipram, piclamilast, and CDP840, this effect was observed after the first 6 h but not after the next 18 h. Mesopram, however, produced a long-lasting reduction of ethanol intake and preference. In the limited access test, rolipram, piclamilast, and mesopram reduced ethanol consumption and total fluid intake and did not change preference for ethanol, whereas CDP840 reduced both consumption and preference without altering total fluid intake. Our results provide novel evidence for a selective role of PDE4 in regulating ethanol drinking in mice. We suggest that inhibition of PDE4 may be an unexplored target for medication development to reduce excessive alcohol consumption.
authors.affiliation: Waggoner Center for Alcohol and Addiction Research, The University of Texas at Austin Austin, TX, USA.
authors.forename: Yuri A
authors.initials: YA
authors.lastname: Blednov
authors.affiliation: Waggoner Center for Alcohol and Addiction Research, The University of Texas at Austin Austin, TX, USA.
authors.forename: Jillian M
authors.initials: JM
authors.lastname: Benavidez
authors.affiliation: Waggoner Center for Alcohol and Addiction Research, The University of Texas at Austin Austin, TX, USA.
authors.forename: Mendy
authors.initials: M
authors.lastname: Black
authors.affiliation: Waggoner Center for Alcohol and Addiction Research, The University of Texas at Austin Austin, TX, USA.
authors.forename: R Adron
authors.initials: RA
authors.lastname: Harris
keywords: CDP840; PDE inhibitors; alcohol; mesopram; piclamilast; rolipram; two-bottle choice